Senti Bio
Senti Bio is a California-based biotechnology company that develops and commercializes cell-based therapeutics for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 11-50
Industries / Tags:
Detailed Senti Bio Information
Geographic Data
Address: 329 Oyster Point Blvd
City: San Francisco
State: CA
Zip: 94080
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$51M
Raised Total:$216M
Social
Metrics
4,439,673Website Global Rank
2,210Website Monthly Traffic
Twitter Followers
Description
Senti Bio is a California-based biotechnology company that develops and commercializes cell-based therapeutics for the treatment of cancer.
Contact Phone:
+16503823281
Contact Email:
Senti Bio went public on 6/9/2022 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/9/2022
IPO Valuation:
$601M
Ticker Symbol:
SNTI
Amount Raised:
$85M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
